FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for <scp>MASH</scp>
Although biopsy remains the gold standard for detecting fibrosis, our results suggest that LSM values <8 kPa after LT for MASH are strongly correlated with absence of significant/advanced fibrosis.
Authors
- Patrice Marqués (ORCID: https://orcid.org/0000-0003-0465-1727)
- Ângela Carvalho‐Gomes (ORCID: https://orcid.org/0000-0001-5424-3479)
- Fernando Díaz‐Fontenla (ORCID: https://orcid.org/0000-0002-4700-0281)
- Isabel Conde (ORCID: https://orcid.org/0000-0001-7863-2233)
- Laura Martínez‐Arenas (ORCID: https://orcid.org/0000-0002-0683-8651)
- Marina Berenguer (ORCID: https://orcid.org/0000-0001-9246-4264)
- Sara Lorente (ORCID: https://orcid.org/0000-0002-3310-1081)
- Carmen Vinaixa (ORCID: https://orcid.org/0000-0001-5060-4556)
- Judith Pérez‐Rojas (ORCID: https://orcid.org/0000-0002-6091-0888)
- Eva Montalvá (ORCID: https://orcid.org/0000-0002-8563-1340)
Institutions
- Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Instituto de Investigación Sanitaria La Fe (ES)
- Universitat Politècnica de València (ES)
Publication Details
- Journal
- Liver International
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1111/liv.16085
- Citations
- 9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.48
Funders
- Generalitat Valenciana
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Instituto de Salud Carlos III